Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Naloxone Nasal Spray vs IV and IM Injection in Healthy Volunteers
NCT03827642Phase 1Completed
- Sponsor
- Insys Therapeutics
- Start
- Apr 2018
- Primary completion
- May 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of naloxone in opioid overdose (4 arms), sponsored by Insys Therapeutics. Primary endpoints: Area Under the Curve From Time 0 to the Last Measured Concentration, AUC Extrapolated to Infinity and 6 more. Started Apr 2018; status: completed.
02
Drugs
naloxone
03
Conditions
opioid overdose
Beyond the preview
Go deeper on NCT03827642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03827642.